Skip to content

The minimum Effective Dose of Carbetocin In Preventing Postpartum Hemorrhage In Cesarean Delivery.

The minimum Effective Dose of Carbetocin In Preventing Postpartum Hemorrhage In Cesarean Delivery : A Factorial Randomized Controlled Trial. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078621
Enrollment
100
Registered
2024-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Injection Carbetocin 100mcg IV: Parturient undergoing Cesarean section will be given Injection Carbetocin 100mcg IV diluted to 10ml and given over 1minute after delivery of the head and

Sponsors

Aarupadai veedu medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Parturients undergoing cesarean section under spinal anaesthesia. ASA II AND III physical status.

Exclusion criteria

Exclusion criteria: Patient Refusal Parturients who are having conditions predisposing to PPH Twin pregnancy, Abnormal placenta, Pre eclampsia, Advanced maternal age more than 35years, BMI more than 35Kg/m2, Anemia Hb less than 8gm%

Design outcomes

Primary

MeasureTime frame
To determine the minimum dose of carbetocin to achieve effective uterine contraction.Timepoint: 2minutes, 5minutes, 10minutes

Secondary

MeasureTime frame
To assess intraoperative blood loss and blood loss in 24 hours across various doses of carbetocin. To assess additional requirements of uterotonic agents from delivery up to 24 hours post surgery. To assess hemodynamic parameters across different doses of carbetocin.Timepoint: 24 hours 24 hours 24 hours

Countries

India

Contacts

Public ContactDr Akshaya M

Aarupadai veedu medical college and hospital

cr.prabhu@gmail.com9843360106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026